QTQinghua Tang

Qinghua Tang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qinghua Tang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prussian blue nanoparticles prevent RANKL ‐induced osteoclastogenesis by scavenging ROS and inactivating NF ‐ κB / MAPK signaling pathways

    by Jiancheng Yang, Qinghua Tang, Siyu Li, Lei Yang, Ming Yang, Qingmei Li, Yan Feng, Mingming Pan, Yuhong Zeng

    The accumulation of intracellular reactive oxygen species (ROS) is widely recognized to stimulate the development of osteoclasts, a crucial factor in the onset of osteoporosis. The ROS scavenging capability of Prussian blue nanoparticles (PBNPs) is exceptional, and they possess excellent biocompatibility. However, the effects of PBNPs on osteoporosis remain unknown. Present study aimed to investigate whether PBNPs could inhibit osteoclast differentiation and prevent ovariectomy (OVX)‐induced bone loss by suppressing ROS. In vitro experiments demonstrated that PBNPs attenuated osteoclastogenesis and downregulated the expression of osteoclast‐related genes. Mechanistically, PBNPs reduce cellular ROS by blocking RANKL‐induced ROS generation and increasing the expression of ROS scavenging enzymes, which in turn block the NF‐κB, ERK, JNK, and p38 pathways, thereby reducing NFATc1 signaling. According to in vivo experimental results, OVX caused a significant rise in ROS in the bone marrow, an increase in osteoclastic number on the bone surface, and substantial bone loss; however, PBNPs significantly reduced ROS and successfully protected OVX‐induced bone damages. In conclusion, this study showed for the first time that PBNPs prevented OVX‐induced bone loss and attenuate osteoclastogenesis, indicating that PBNPs may be a viable alternative therapy for the management of osteoclast‐associated bone disorders.


  • Epidemiological characteristics of traumatic spinal cord injury in Xi’an, China

    by Jinpeng Du, Dingjun Hao, Baorong He, Liang Yan, Qinghua Tang, Zilong Zhang, Yuhang Wang, Heng Li, Yang Cao, Chao Jiang, et al.

    Study design A hospital-based retrospective epidemiological study. Objective To describe the demographic and epidemiological characteristics of patients with traumatic spinal cord injury (TSCI) in Xi’an to help health-related institutions formulate corresponding measures. Setting People with TSCI, all spine centres and orthopaedic centres in Xi’an, China. Methods We retrospectively reviewed the medical records of the all spine centers or orthopedic centers in Xi’an according to the International Classification of Disease Version 10 (ICD-10) and diagnostic code of TSCI. Variables included gender, age, medical insurance, etiology, occupation, level of injury, and severity of injury, multiple injury, complication, treatment, and so on. Results The study included the medical records of 1730 patients with TSCI from 2014 to 2018. The estimated annual incidence rate increased from 39.0 cases (95% CI, 34.7–43.3 cases) per 1 million persons in 2014 to 43.2 cases (95% CI, 39.0–47.5 cases) per 1 million persons in 2018. The leading cause of TSCI was high falls (35.5%, 614 cases). The most common injury site was the cervical spinal cord, accounting for 55.7% (963 cases). The degree of injury severity with the highest proportion was incomplete tetraplegia (47.2%, 816 cases). In addition, 71.4% (1236 cases) of TSCI cases had spinal fracture or dislocation. Conclusions There are specific epidemiological characteristics of TSCI patients in Xi’an, and preventive measures are suggested to be based on the characteristics of the different types of patients with TSCI and focused on high-risk groups.